Linde and Praxair Sign Merger Agreement

(c) Linde
(c) Linde

German industrial gases group Linde has finally signed a formal merger agreement with US rival Praxair after the two companies reached a deal in principle. Negotiations to finalize the agreement fell behind schedule after shareholders’ representatives criticized the proposal at Linde’s annual general meeting on May 10, adding to the discontent previously expressed by employee representatives who are worried about job losses. 

Wolfgang Reitzle, Linde’s supervisory board chairman, said last month that he would be prepared to use his double vote to seal the deal in the case of a split between shareholder and worker representatives. Linde’s labor representatives have fiercely opposed the merger, mainly because moving the headquarters out of Germany would dilute their ability to have a say in strategic decisions. The companies have said the combined group would operate out of Danbury, Connecticut, USA, headed by Praxair’s CEO Steven Angel, with Linde supervisory board chairman Wolfgang Reitzle as chairman.

The all-share “merger of equals” is consistent with the structure announced on Dec. 20, 2016 and must now be approved by  Praxair’s board of directors as well as Linde’s executive and supervisory boards. Citing sources, German newspaper WirtschaftsWoche said Linde's supervisory board would vote on the proposal next week.

Analysts at Bernstein have estimated that the combined entity could account for 40% of the global industrial gases market, displacing Air Liquide as the market leader.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.